MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1590/1516-3180.2019.0461.r2.19022020

Медицинская библиотека · Sao Paulo medical journal = Revista paulista de medicina · 2020

Risk factors associated with drug therapy among elderly people with Alzheimer's disease: a cross-sectional study.

Forgerini Marcela, Herdeiro Maria Teresa, Galduróz José Carlos Fernandes, Mastroianni Patrícia de Carvalho

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Improving knowledge and establishing strategies and policies for better patient safety are worldwide priorities.

OBJECTIVE

To evaluate drug safety among elderly people with Alzheimer's disease (AD).

DESIGN AND

SETTING

Cross-sectional study among elderly people within the National AD Assistance Protocol (PCDTDA/MS) who were living in the municipality of Araraquara, Brazil, in 2017.

METHODS

Through interviews conducted with relatives/caregivers of elderly people with diagnoses of AD, the following variables were evaluated: comorbidities, drug therapy used, use of potentially inappropriate medications for the elderly (PIMs), presence of potentially inappropriate interactions (PIIs) and medication regimen complexity index. Factors associated with AD severity were also evaluated. Multivariate and simple logistic regressions were applied.

RESULTS

143 elderly people enrolled in PCDTDA/MS were analyzed. The majority were women (67.1%); assisted only through the public healthcare system (75.5%); polymedicated (57.4%); using at least one PIM (63.6%); presenting at least one PII (63.6%); and under drug therapy of low to medium complexity (92.2%). No semi-annual monitoring of the effectiveness of PCDTDA/MS drugs was identified. The proportion using AD drug therapy at daily doses differing from those recommended by the World Health Organization was 75.6%. However, these doses were not associated with drug risk.

CONCLUSION

The data from this study raise the hypothesis that use of polypharmacy might show a correlation with severity of AD. The drug safety risk may be associated with comorbidities of the metabolic syndrome, anxiety and off-label use of PIMs, such as risperidone and quetiapine, and benzodiazepines (i.e. clonazepam and flunitrazepam).

Для цитирования: Forgerini Marcela, Herdeiro Maria Teresa, Galduróz José Carlos Fernandes, Mastroianni Patrícia de Carvalho. Risk factors associated with drug therapy among elderly people with Alzheimer's disease: a cross-sectional study.. Sao Paulo medical journal = Revista paulista de medicina. 2020. DOI: 10.1590/1516-3180.2019.0461.r2.19022020.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.